CClinicalTrials.gg
Sign In
Status unknownNCT05567549Updated Oct 5, 2022

Evaluation of Sarcopenia in Elderly at the Emergency Department

An observational study in Sarcopenia, sponsored by Ege University. Status unknown at 1 site in Turkey. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2022-10-05.

Sponsored by Ege University · Observational

The sponsor has not verified this record recently (last verified Oct 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Other
Enrollment
300
Ages
65 Years and older
Sex
All
01

Study summary

The goal of this observational study is to evaluate in elderly patients for the frequency of sarcopenia and its relationship with mortality in a university hospital.

The main questions it aims to answer are;

  1. What is the frequency of sarcopenia in elderly patients at emergency department?
  2. Is sarcopenia associated with mortality in an elderly patient admitted to the emergency department?
02

Conditions studied

  • Sarcopenia

Browse trials for

03

In context

Sarcopenia

1,208 studies on the registry are indexed under Sarcopenia; 402 are open to participants now.

This study's planned enrollment of 300 is above the median of 120 across 419 observational studies indexed under Sarcopenia.

Browse Sarcopenia studies →

Lead sponsor

Ege University is the lead sponsor of 365 studies on the registry; 46 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patients over 65 years of age, who can walk independently, who do not have lower extremity fractures or neuromuscular disease, will constitute the study population.

The mortality rate over the age of 65 was found to be 11%. Considering that the mortality rate with sarcopenia was 28%, it was found that 63 patients were required for the effect of sarcopenia on mortality with a 95% confidence interval and 0.5% margin of error. Since the incidence of sarcopenia in the emergency department was 33%, 200 patients were planned to be included in the study.

Inclusion criteria

  1. Above the age of 65 admitted to the emergency department
  2. Able to walk without support
  3. No lower extremity fracture
  4. No disease with neuromuscular involvement

Exclusion criteria

Exclusion Criteria:

  1. In the presence of a cerebrovascular event
  2. Those in need of critical intervention when applying to the emergency department
  3. Unconscious patients
05

Study design

Observational model
Case-only
Time perspective
Other
Enrollment
300 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Mortality

    Time frame: 0-28 days

07

Study locations

1 site
08

References and documents

Publications

  • Morley JE. Sarcopenia: diagnosis and treatment. J Nutr Health Aging. 2008 Aug-Sep;12(7):452-6. doi: 10.1007/BF02982705. No abstract available. PubMed 18615226 ↗
  • Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010 Jul;39(4):412-23. doi: 10.1093/ageing/afq034. Epub 2010 Apr 13. PubMed 20392703 ↗
  • Roberts S, Collins P, Rattray M. Identifying and Managing Malnutrition, Frailty and Sarcopenia in the Community: A Narrative Review. Nutrients. 2021 Jul 5;13(7):2316. doi: 10.3390/nu13072316. PubMed 34371823 ↗
  • Hung SK, Kou HW, Hsu KH, Wu CT, Lee CW, Leonard Goh ZN, Seak CK, Chen-Yeen Seak J, Liu YT, Seak CJ; SPOT investigators. Sarcopenia is a useful risk stratification tool to prognosticate splenic abscess patients in the emergency department. J Formos Med Assoc. 2021 Mar;120(3):997-1004. doi: 10.1016/j.jfma.2020.08.039. Epub 2020 Sep 9. PubMed 32917483 ↗
  • McQuade C, Kavanagh DO, O'Brien C, Hunter K, Nally D, Hickie C, Ward E, Torreggiani WC. CT-determined sarcopenia as a predictor of post-operative outcomes in patients undergoing an emergency laparotomy. Clin Imaging. 2021 Nov;79:273-277. doi: 10.1016/j.clinimag.2021.05.015. Epub 2021 May 18. PubMed 34171595 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 5, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05567549
Lead sponsor
Ege University
Responsible party
Ozge Can. MD (MD, Ege University) — Principal investigator
First posted
Oct 5, 2022
Start date
Oct 10, 2022 (estimated)
Primary completion
Jul 10, 2023 (estimated)
Completion
Sep 10, 2023 (estimated)
Last update
Oct 5, 2022
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Sarcopenia→

Other studies from this sponsor

Ege University

Start the discussion